Imbio PHA (4.0.0) vs Vista OS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio (a subsidiary of 4DMedical)
VS
by Vista AI

AI Verdict

Imbio PHA is designed for post-acquisition analysis of CT pulmonary angiogram (CTPA) scans, providing automated measurements for diagnosing and risk-stratifying conditions like pulmonary embolism and hypertension. In contrast, Vista OS focuses on automating and simplifying the acquisition process for cardiac MRI, aiming to enhance consistency and productivity during the scan itself. Therefore, while both leverage AI in cardiac imaging, they serve distinct purposes at different stages of the patient care workflow.

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA if your primary need is the automated, AI-powered analysis of existing CT pulmonary angiogram (CTPA) scans. This tool is ideal for rapidly assessing right ventricular dilation and aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension from CTPA data. It provides quick, standardized measurements and reports to support clinical decision-making.

View Imbio PHA (4.0.0) →

Choose Vista OS if…

Choose Vista OS if your goal is to automate and standardize the cardiac MRI acquisition process itself, improving efficiency and consistency. This software is best suited for imaging centers looking to streamline scan planning, optimize image quality with real-time adjustments, and enhance patient access to high-quality cardiac MRI by simplifying the technologist's workflow.

View Vista OS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Imbio PHA (4.0.0) Vista OS
Deployment Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). Vista AI Scan installs on customer-provided hardware and communicates directly with GE and Siemens MRI scanners.
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Vista OS

Vista OS significantly enhances usability by automating complex cardiac MRI acquisition tasks like scan planning and parameter tuning, which streamlines the technologist's workflow and reduces manual steps. This automation aims to make high-quality cardiac MRI more accessible to a broader range of staff, leading to faster and more consistent scans. Imbio PHA, while automated for post-processing, addresses a different part of the imaging workflow.

Clinical Value

Imbio PHA (4.0.0)

Imbio PHA offers direct clinical value by providing automated, accurate measurements of cardiac structures and clinically relevant ratios from CTPA scans, which are well-accepted biomarkers for diagnosing and risk stratifying pulmonary embolism and hypertension. This directly aids in critical diagnostic decisions. Vista OS, while improving image acquisition quality and efficiency, provides more indirect clinical value by enabling better images for subsequent diagnosis.

Pricing & Value

Tie

Both Imbio PHA and Vista OS explicitly state that their pricing is not publicly disclosed and requires direct contact for a quote. Without any transparent pricing information or detailed cost-benefit analyses available for either product, it is impossible to conduct a head-to-head comparison of their pricing and overall value.

Enterprise Readiness

Imbio PHA (4.0.0)

Imbio PHA demonstrates stronger enterprise readiness by explicitly stating it is HIPAA compliant with third-party certification by Compliancy Group, and implies BAA availability. It also offers flexible deployment options including cloud and on-premise. While Vista OS's documentation indicates internal HIPAA policies and multi-site deployment, it lacks explicit third-party certification or public BAA confirmation.

Innovation

Vista OS

Vista OS shows greater innovation by applying AI to automate and simplify the complex cardiac MRI acquisition process itself, including features like automated scan planning, parameter tuning, and real-time motion detection. This directly addresses significant operational challenges in MRI, aiming to standardize image quality and expand access to specialized imaging. Imbio PHA, while valuable, applies AI to post-acquisition analysis, which is a more established application of AI in radiology.

Support & Docs

Imbio PHA (4.0.0)

Imbio PHA clearly outlines its robust support infrastructure, offering 24/7/365 phone and email support globally, and explicitly states that user manuals and product documentation are available upon request. In contrast, Vista OS's public resources for support and documentation are less detailed, requiring potential customers to contact them directly for such information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Imbio PHA (4.0.0) Vista OS
Name Imbio PHA (4.0.0) Vista OS
Company Imbio Vista AI, Inc.
Description FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. FDA-cleared, AI-powered software that automates and simplifies cardiac MRI acquisition, enhancing consistency, productivity, and patient access to high-quality imaging.
Key Features (Cardiac Measurement/Acquisition) Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios. AI-powered automated cardiac MRI acquisition; Automated scan planning & localization in 30 seconds; Parameter tuning for optimal image settings; Real-time motion & artifact detection (on certain sequences); In-line analysis before patient leaves.
Imaging Modality CT pulmonary angiogram (CTPA) scans Cardiac MRI
Specialties Cardiology, Pulmonology, Radiology Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Vista OS.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio PHA (4.0.0) is designed to process CT pulmonary angiogram (CTPA) scans to measure cardiac structures. Vista OS, on the other hand, is an AI-powered software that automates and simplifies cardiac MRI acquisition.
Imbio PHA (4.0.0) aims to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. Vista OS focuses on enhancing consistency, productivity, and patient access to high-quality cardiac MRI by automating the acquisition process.
Imbio PHA (4.0.0) offers flexible deployment options including Cloud, Enterprise (on-premise), or via partners, and integrates with native DICOM tools and workflows. Vista OS is a software-only solution that runs on a stand-alone Linux-based computer workstation and integrates with GE or Siemens MRI systems, as well as common PACS and post-processing software.
Imbio PHA (4.0.0) provides automated measurements of right and left ventricle diameters, main pulmonary artery and aorta diameters, RV/LV and PA/Ao ratios, annotated DICOM images, and summary reports in PDF format. Vista OS offers automated scan planning and localization, parameter tuning for optimal image settings, real-time motion and artifact detection (on certain sequences), and in-line analysis before the patient leaves.
Imbio PHA (4.0.0) integrates with native DICOM tools and workflows, implying broad compatibility with DICOM-compliant systems. Vista OS is specifically compatible with GE and Siemens MRI systems.
AI Tool Finder
AI-powered search. Results may not be comprehensive.